Global Dermatophytic Onychomycosis Treatment Market to Reach $9.5 Billion by 2030
The global market for Dermatophytic Onychomycosis Treatment estimated at US$6.4 Billion in the year 2022, is projected to reach a revised size of US$9.5 Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2022-2030. Topical Therapy, one of the segments analyzed in the report, is projected to record 6.1% CAGR and reach US$6.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Systemic Therapy segment is readjusted to a revised 3.4% CAGR for the next 8-year period.
The U.S. Market is Estimated at $1.9 Billion, While China is Forecast to Grow at 4.8% CAGR
The Dermatophytic Onychomycosis Treatment market in the U.S. is estimated at US$1.9 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.7 Billion by the year 2030 trailing a CAGR of 4.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.1% and 4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.Select Competitors (Total 44 Featured) -
- Allergan PLC
- Galderma SA
- GlaxoSmithKline PLC
- Johnson & Johnson
- Moberg Pharma AB
- NovaBiotics Ltd
- Novartis AG
- Pfizer, Inc.
- Sanofi SA
- Valeant Pharmaceuticals International, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- Dermatophytic Onychomycosis Treatment - Global Key Competitors Percentage Market Share in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 2: World Historic Review for Dermatophytic Onychomycosis Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 3: World 16-Year Perspective for Dermatophytic Onychomycosis Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
- Table 4: World Recent Past, Current & Future Analysis for Systemic Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 5: World Historic Review for Systemic Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 6: World 16-Year Perspective for Systemic Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Topical Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 8: World Historic Review for Topical Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 9: World 16-Year Perspective for Topical Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 10: World Recent Past, Current & Future Analysis for Device-based Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 11: World Historic Review for Device-based Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 12: World 16-Year Perspective for Device-based Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 13: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 14: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 15: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 16: World Recent Past, Current & Future Analysis for Dermatology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 17: World Historic Review for Dermatology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 18: World 16-Year Perspective for Dermatology Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 19: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 20: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 21: World 16-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 22: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 23: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 24: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 25: World Dermatophytic Onychomycosis Treatment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
UNITED STATES
- Dermatophytic Onychomycosis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- Table 26: USA Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 27: USA Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 28: USA 16-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Topical Therapy, Systemic Therapy and Device-based Therapy for the Years 2014, 2023 & 2030
- Table 29: USA Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 30: USA Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 31: USA 16-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses for the Years 2014, 2023 & 2030
CANADA
- Table 32: Canada Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 33: Canada Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 34: Canada 16-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Topical Therapy, Systemic Therapy and Device-based Therapy for the Years 2014, 2023 & 2030
- Table 35: Canada Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 36: Canada Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 37: Canada 16-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses for the Years 2014, 2023 & 2030
JAPAN
- Dermatophytic Onychomycosis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- Table 38: Japan Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 39: Japan Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 40: Japan 16-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Topical Therapy, Systemic Therapy and Device-based Therapy for the Years 2014, 2023 & 2030
- Table 41: Japan Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 42: Japan Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 43: Japan 16-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses for the Years 2014, 2023 & 2030
CHINA
- Dermatophytic Onychomycosis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- Table 44: China Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 45: China Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 46: China 16-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Topical Therapy, Systemic Therapy and Device-based Therapy for the Years 2014, 2023 & 2030
- Table 47: China Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 48: China Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 49: China 16-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses for the Years 2014, 2023 & 2030
EUROPE
- Dermatophytic Onychomycosis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- Table 50: Europe Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 51: Europe Historic Review for Dermatophytic Onychomycosis Treatment by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 52: Europe 16-Year Perspective for Dermatophytic Onychomycosis Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
- Table 53: Europe Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 54: Europe Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 55: Europe 16-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Topical Therapy, Systemic Therapy and Device-based Therapy for the Years 2014, 2023 & 2030
- Table 56: Europe Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 57: Europe Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 58: Europe 16-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses for the Years 2014, 2023 & 2030
FRANCE
- Dermatophytic Onychomycosis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- Table 59: France Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 60: France Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 61: France 16-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Topical Therapy, Systemic Therapy and Device-based Therapy for the Years 2014, 2023 & 2030
- Table 62: France Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 63: France Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 64: France 16-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses for the Years 2014, 2023 & 2030
GERMANY
- Dermatophytic Onychomycosis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- Table 65: Germany Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 66: Germany Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 67: Germany 16-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Topical Therapy, Systemic Therapy and Device-based Therapy for the Years 2014, 2023 & 2030
- Table 68: Germany Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 69: Germany Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 70: Germany 16-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses for the Years 2014, 2023 & 2030
ITALY
- Table 71: Italy Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 72: Italy Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 73: Italy 16-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Topical Therapy, Systemic Therapy and Device-based Therapy for the Years 2014, 2023 & 2030
- Table 74: Italy Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 75: Italy Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 76: Italy 16-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses for the Years 2014, 2023 & 2030
UNITED KINGDOM
- Dermatophytic Onychomycosis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- Table 77: UK Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 78: UK Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 79: UK 16-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Topical Therapy, Systemic Therapy and Device-based Therapy for the Years 2014, 2023 & 2030
- Table 80: UK Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 81: UK Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 82: UK 16-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses for the Years 2014, 2023 & 2030
REST OF EUROPE
- Table 83: Rest of Europe Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 84: Rest of Europe Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 85: Rest of Europe 16-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Topical Therapy, Systemic Therapy and Device-based Therapy for the Years 2014, 2023 & 2030
- Table 86: Rest of Europe Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 87: Rest of Europe Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 88: Rest of Europe 16-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses for the Years 2014, 2023 & 2030
ASIA-PACIFIC
- Dermatophytic Onychomycosis Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- Table 89: Asia-Pacific Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 90: Asia-Pacific Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 91: Asia-Pacific 16-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Topical Therapy, Systemic Therapy and Device-based Therapy for the Years 2014, 2023 & 2030
- Table 92: Asia-Pacific Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 93: Asia-Pacific Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 94: Asia-Pacific 16-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses for the Years 2014, 2023 & 2030
REST OF WORLD
- Table 95: Rest of World Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 96: Rest of World Historic Review for Dermatophytic Onychomycosis Treatment by Segment - Topical Therapy, Systemic Therapy and Device-based Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 97: Rest of World 16-Year Perspective for Dermatophytic Onychomycosis Treatment by Segment - Percentage Breakdown of Value Sales for Topical Therapy, Systemic Therapy and Device-based Therapy for the Years 2014, 2023 & 2030
- Table 98: Rest of World Recent Past, Current & Future Analysis for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 99: Rest of World Historic Review for Dermatophytic Onychomycosis Treatment by End-Use - Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
- Table 100: Rest of World 16-Year Perspective for Dermatophytic Onychomycosis Treatment by End-Use - Percentage Breakdown of Value Sales for Dermatology Clinics, Hospitals, Retail Pharmacies and Other End-Uses for the Years 2014, 2023 & 2030
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Allergan PLC
- Galderma SA
- GlaxoSmithKline PLC
- Johnson & Johnson
- Moberg Pharma AB
- NovaBiotics Ltd
- Novartis AG
- Pfizer, Inc.
- Sanofi SA
- Valeant Pharmaceuticals International, Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 193 |
| Published | April 2024 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 6.4 Billion |
| Forecasted Market Value ( USD | $ 9.5 Billion |
| Compound Annual Growth Rate | 5.1% |
| Regions Covered | Global |
